host
defens
invad
pathogen
depend
rapid
effect
earli
respons
infect
organ
one
first
respons
viral
infect
product
antivir
cytokin
includ
interferon
ifn
tumor
necrosi
factor
tnf
produc
cytokin
act
directli
infect
uninfect
cell
activ
cellular
constitu
innat
immun
system
promot
b
cell
respons
effect
cytokin
pleiotrop
influenc
dose
well
presenc
absenc
cytokin
antivir
state
induc
cytokin
alon
extens
studi
certain
cytokin
combin
shown
synergist
distinct
induc
cytokin
alon
simpli
addit
review
summar
find
novel
synergist
antivir
state
induc
combin
typei
typeii
interferon
either
interferon
type
plu
tnf
knowledg
first
time
subject
review
past
year
varieti
ifn
protein
discov
group
typesi
ii
iii
although
ifn
alon
effect
inhibitor
virus
vesicular
stomat
viru
vsv
encephalomyocard
viru
emcv
mani
virus
evolv
sophist
mechan
subvert
host
ifn
respons
exampl
human
cytomegaloviru
hcmv
mani
poxvirus
inhibit
typesi
ii
ifnstimul
antivir
immunoregulatori
respons
multipl
step
sever
studi
howev
shown
virus
normal
resist
effect
typei
typeii
ifn
separ
suscept
ifn
use
combin
exampl
ifnab
ifng
synergist
inhibit
replic
herp
simplex
viru
vitro
vivo
likewis
ifng
synerg
ifnab
inhibit
vitro
replic
member
herp
viru
famili
hcmv
varicellazost
viru
vzv
pseudorabi
viru
prv
well
decreas
transform
human
umbil
cord
lymphocyt
epsteinbarr
viru
ebv
viru
famili
earlier
report
indic
combin
ifng
ifnab
abl
block
replic
sever
virus
includ
mengo
viru
vsv
vaccinia
viru
vv
sindbi
viru
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
hepat
c
viru
hcv
mous
hepat
viru
lassa
viru
footandmouth
diseas
viru
fmdv
initi
report
novel
synergist
interact
typei
typeii
ifn
origin
describ
mous
system
potenti
antivir
action
ifn
combin
ifnab
andor
potenti
sinc
extend
human
system
combin
ifng
ifna
ifnb
demonstr
potenti
combin
ifna
ifnb
demonstr
addit
protect
effect
indic
compar
correl
exist
potenti
mous
human
system
fact
typei
ifn
use
cell
surfac
receptor
similar
signal
pathway
come
littl
surpris
combin
ifna
ifnb
result
addit
respons
profil
convers
typesi
ii
ifn
bind
distinct
cell
surfac
receptor
signal
substanti
diverg
pathway
diverg
downstream
signal
pathway
like
account
synerg
observ
ifng
ifna
ifng
ifnb
combin
despit
appar
widespread
recognit
synergist
antivir
action
typesi
ii
ifn
exact
mechan
underli
phenomenon
remain
mostli
undefin
conclud
mechan
ifnb
ifng
achiev
inhibit
replic
vero
cell
nt
involv
inhibit
viral
adsorpt
andor
entri
instead
infer
combin
ifnb
ifng
cell
suppress
replic
noncytolyt
via
prevent
detect
viral
immedi
earli
ie
earli
e
protein
synthesi
twothird
cell
block
viral
dna
synthesi
remain
onethird
cell
similar
find
observ
hcmv
prv
mechan
viral
inhibit
take
place
howev
total
clear
abil
ifn
protect
variou
viral
infect
deriv
complex
transcript
program
initi
combin
ifng
ifnab
induc
antivir
state
rapidli
addit
either
cytokin
alon
result
rapid
onset
cellular
transcript
recent
report
peng
et
al
defin
two
type
synergi
first
synergi
defin
synergi
independ
action
ifnb
ifng
induc
distinct
categori
gene
work
synergist
manner
inhibit
viral
replic
exampl
ifnb
induc
antivir
protein
rigi
oligoadenyl
synthetas
ifng
induc
antivir
protein
indoleamin
indo
although
protein
synergist
induc
function
howev
synergist
inhibit
viral
replic
second
synergi
cooper
action
describ
posit
interact
ifnb
ifng
lead
much
higher
level
gene
express
rel
either
use
alon
exampl
induc
high
level
follow
addit
ifnb
plu
ifng
induc
presenc
either
cytokin
alon
two
form
synergi
function
simultan
exampl
combin
ifnb
ifng
synergist
induc
downregul
decoy
receptor
synergi
cooper
action
simultan
coordin
upregul
downregul
inhibitor
lead
increas
apoptosi
synergi
independ
action
possibl
role
apoptosi
contrast
prior
find
pierc
et
al
indic
combin
ifnb
ifng
treatment
nt
prime
vero
cell
undergo
virusinduc
apoptosi
appar
contrast
may
perhap
owe
differ
cell
type
andor
moi
use
one
case
combin
ifn
ad
follow
infect
vero
cell
moi
case
primari
human
fibroblast
cell
pretreat
combin
ifn
h
infect
moi
higher
notabl
peng
et
al
indic
signific
differ
apoptosi
combin
individu
treatment
found
infect
primari
human
fibroblast
moi
clearli
elucid
biolog
role
ifnstimul
gene
crucial
order
abl
better
understand
typesi
ii
ifn
util
synergi
combat
viral
replic
tnf
appear
trigger
multipl
antivir
mechan
also
abl
synerg
typesi
ii
ifn
promot
antivir
activ
although
synergi
tnf
typei
interferon
report
two
decad
ago
littl
attent
devot
toward
better
understand
antivir
potenti
cytokin
combin
mestan
et
al
report
signific
enhanc
antivir
state
cell
vsv
combin
tnf
low
concentr
either
ifnb
ifng
likewis
antivir
activ
tnf
human
foreskin
fibroblast
emcv
also
synerg
subeffect
concentr
autocrin
ifnb
addit
result
lab
demonstr
potent
antivir
synergist
interact
tnf
ifnb
myxoma
viru
primari
human
monocyt
fibroblast
submit
public
sever
report
indic
tnf
induc
ifnb
sever
cell
type
rais
question
whether
sole
role
tnf
establish
antivir
state
induc
ifnb
activ
antivir
activ
howev
model
would
explain
synerg
antivir
activ
observ
treatment
cell
tnf
exogen
ifnb
would
rather
predict
addit
effect
fact
recent
report
demonstr
synergist
activ
inflammatori
gene
observ
follow
addit
tnf
low
concentr
ifnb
uml
earli
time
point
product
endogen
ifnb
sustain
express
inflammatoryrel
gene
lead
subsequ
express
classic
interferonrespons
gene
includ
known
mediat
antivir
respons
similarli
combin
tnf
ifnb
synergist
augment
express
gene
alreadi
induc
tnf
andor
ifnb
induc
novel
set
gene
primari
human
cell
induc
either
cytokin
alon
unpublish
data
undoubtedli
studi
need
determin
function
relev
induc
gene
overal
antivir
state
order
reveal
aspect
mechanist
detail
underli
synergist
interact
tnf
ifnb
sever
group
shown
tnf
ifng
present
simultan
induc
synergist
antivir
state
inhibit
viral
gene
express
lower
viral
titer
greater
extent
treatment
either
cytokin
individu
synergist
antivir
state
shown
effect
divers
array
virus
includ
hcmv
murin
cytomegaloviru
mcmv
vsv
emcv
adenoviru
sever
potenti
mechan
antivir
synergi
tnf
ifng
propos
group
demonstr
pretreat
ifng
result
increas
tnf
receptor
tnfr
express
well
increas
bind
tnf
cell
surfac
pretreat
ifng
howev
result
increas
tnfr
express
increas
affin
receptor
tnf
lead
conclus
increas
might
insuffici
caus
multilog
reduct
viral
titer
observ
mani
system
addit
treatment
cell
ifng
result
increas
tnfr
express
without
correspond
increas
tnf
function
thu
increas
tnfr
express
might
play
role
synergi
tnf
ifng
like
addit
mechan
work
second
mechan
hypothes
synergi
tnf
ifng
regul
cellular
tryptophan
store
sever
group
note
inhibit
viral
growth
caus
tnf
ifng
abrog
addit
l
tryptophan
addit
ltryptophan
thought
counter
enhanc
express
tryptophandegrad
enzym
indo
indo
strongli
upregul
ifng
alon
addit
tnf
ifng
synergist
enhanc
express
synergi
cooper
action
interestingli
combin
ifnb
tnf
result
synergist
upregul
indo
neither
cytokin
alon
abl
unpublish
observ
thu
combin
tnf
ifnb
might
induc
antivir
state
mimic
induc
ifng
alon
final
hypothes
observ
synergist
antivir
state
induc
tnf
ifng
might
mediat
presenc
third
cytokin
mention
earlier
sever
group
shown
treatment
cell
tnf
result
secret
ifnb
deplet
ifnb
shown
result
loss
synergi
tnf
ifng
data
suggest
synergist
antivir
state
observ
follow
treatment
tnf
ifng
might
result
synergi
ifng
ifnb
ifnb
howev
alway
secret
follow
treatment
tnf
unpublish
observ
ifnb
previous
also
shown
synerg
directli
tnf
thu
ifnb
might
occasion
play
role
synergi
tnf
ifng
like
mediat
one
reason
mani
differ
mechan
propos
antivir
synergi
tnf
ifng
differ
group
report
diverg
result
follow
treatment
cytokin
exampl
sever
group
shown
treatment
cell
tnf
ifng
block
hcmv
replic
stage
earli
gene
express
contrast
group
shown
follow
treatment
tnf
ifng
earli
gene
express
dna
synthesi
protein
express
mcmv
adenoviru
prv
remain
unalt
case
mcmv
adenoviru
treatment
tnf
ifng
inhibit
process
viral
protein
critic
virion
matur
treatment
cell
tnf
ifng
inhibit
prv
titer
elimin
abil
viru
spread
cell
cell
one
possibl
reason
dispar
distinct
characterist
viru
exampl
hcmv
mcmv
relat
virus
similar
replic
cycl
howev
display
differ
set
immunomodulatori
gene
uniqu
set
gene
could
caus
hcmv
mcmv
uniqu
respons
antivir
state
induc
combin
tnf
ifng
hypothesi
support
observ
least
primari
human
fibroblast
differ
member
poxviru
famili
encod
distinct
immunomodulatori
gene
display
differenti
sensit
synergist
antivir
state
induc
tnf
ifnb
unpublish
observ
altern
small
differ
experiment
design
might
lead
substanti
dispar
induc
synergist
state
exampl
shown
tnf
ad
either
simultan
ifng
synergist
reduc
titer
vsv
fourlog
system
howev
tnf
ad
hour
ifng
synergist
effect
addit
sever
group
note
addit
ifng
alon
block
earli
protein
synthesi
low
moi
use
higher
moi
viral
protein
synthesi
progress
normal
presenc
ifng
even
though
viral
titer
still
block
studi
directli
address
antivir
state
induc
combin
ifng
tnf
seem
like
subtl
differ
experiment
design
could
larg
impact
observ
antivir
effect
also
possibl
ifn
tnf
receptor
densiti
signal
amplitud
vari
cultur
cell
passag
cultur
report
date
howev
agre
synergi
tnf
ifn
occur
mainli
level
gene
transcript
suggest
simultan
treatment
cytokin
synergist
activ
signal
transduct
pathway
transcript
factor
surprisingli
littl
known
potenti
synergist
gene
activ
rubi
et
al
demonstr
antivir
effect
tnf
requir
tnfr
howev
requir
either
receptor
examin
context
tnf
synergi
ifng
robinson
et
al
show
treatment
tnf
ifng
result
activ
signal
transduct
molecul
well
synergist
increas
express
dna
bind
activ
transcript
factor
similar
result
recent
shown
treatment
human
macrophag
tnf
alon
lead
depend
activ
result
increas
express
interferon
depend
proinflammatori
gene
indo
thu
sever
differ
signal
pathway
transcript
factor
implic
antivir
synergi
tnf
ifng
work
howev
need
mechan
cytokineinduc
synerg
pathway
fulli
elucid
taken
togeth
data
discuss
point
network
multipl
interact
cytokin
exert
activ
lead
induct
effect
comprehens
synergist
antivir
state
given
phenomenon
origin
observ
year
ago
surprisingli
littl
still
known
synergist
antivir
mechan
involv
cytokin
combin
display
similar
synergi
similar
synergist
state
induc
differ
cytokin
combin
synergi
translat
viral
inhibit
signal
pathway
involv
critic
inhibit
mani
virus
abl
counter
antivir
state
induc
individu
cytokin
effect
unabl
counter
synergist
antivir
state
importantli
role
synergi
play
antivir
respons
infect
host
clearli
mani
question
remain
answer
hope
review
spark
renew
interest
import
yet
somewhat
neglect
part
cytokin
immunolog
yarilina
parkmin
kh
antoniv
hu
x
ivashkiv
lb
tnf
activ
autocrin
loop
lead
sustain
express
chemokin
type
interferonrespons
gene
nat
immunol
paper
show
induct
inflammatori
gene
requir
synergist
interplay
tnf
ifnb
combin
cytokin
set
posit
feedback
loop
sustain
amplifi
inflammatori
state
